Sunday, July 23, 2017 1:37:51 PM
Also the FDA is not requiring more data- there is no significant short term capital drain - there is no urgency to begin NDA or complete a deal. If it takes until yearend so be it.
Having said that I expect an announcement within 90 days as I believe interested players and their offers are on the table- and further delay is unlikely to enhance value significantly.!I believe SCLC trial not being released as part of non disclosure agreements with serious parties.
I am long- think a buyout likely- probably 3-4 dollar range- because we have no leverage. We can not bring this to market on our own. I hope and pray that multiple buyers are elevating the price but after experiencing astellas rape OCAT shareholders (like me), I believe an equitable valuation is unlikely.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM